Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-014195
Filing Date
2025-02-05
Accepted
2025-02-05 09:20:22
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3834
  Complete submission text file 0000950170-25-014195.txt   5267
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Issuer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ERASCA, INC. 3115 MERRYFIELD ROW, SUITE 300 SAN DIEGO CA 92121
Business Address
Morris Shannon (Reporting) CIK: 0001973527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40602 | Film No.: 25591114